Alzheimer's Disease Trial, Recruiting NCT07272811 Sponsor: IRCCS San Raffaele Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07272811
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to sign a consent form agreeing to take part in the study
  • People aged between 55 and 80 years old
  • People whose daily life is either not affected, or only minimally affected, by any cognitive difficulties

For the Healthy Control group specifically:

  • People who score 28 or above on a standard memory and thinking test called the Mini Mental State Examination
  • People who do not have any notable memory or thinking problems when compared to others of a similar age, sex, and education level, as measured by standardised cognitive tests

For the Mild Cognitive Impairment (aMCI) group specifically:

  • People who have noticed memory or thinking difficulties themselves, or whose family member or doctor has noticed these difficulties
  • People whose overall score on a standard thinking test falls within a typical range for their age and education level
  • People who show specific memory or thinking difficulties on standardised tests that are noticeably below what would be expected for their age and education level

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who do not wish to sign the consent form
  • People with significant hearing loss or significant vision problems
  • People with a current or past history of a psychiatric illness
  • People with a current or past diagnosis of a degenerative condition affecting the brain or nervous system
  • People with a history of serious ongoing physical health conditions (confirm with trial site)
  • People with a history of stroke or other events affecting blood flow to the brain
  • People with a history of alcohol misuse or use of mind-altering substances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00390226433051

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
15 December 2021
Est. completion
1 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Development of NAP4A Platform

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov